Global Subcutaneous Medicine Delivery Devices Market Research Report 2022

Publisher Name :
Date: 13-Jan-2022
No. of pages: 101
Inquire Before Buying

The research report includes specific segments

By Region (country),

By Company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Implantable Subcutaneous Medicine Delivery Device

- Injection Type Subcutaneous Medicine Delivery Device

Segment by Application

- Hospitals

- Clinics

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Colombia

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Boehringer Ingelheim

- Eli Lily

- Galaxo

- HMD pharmaceuticals

- Merck

- Novartis

- Novo Nordisk

- Pfizer

- Sanofi

- Teva Pharmaceutical

- Zogenix

- BD

- Insulet Corporation

- Enable Injections

- West Pharmaceutical Services

- Ypsomed AG

- Elcam Medical

- Amgen

- Wilhelm Haselmeier

Global Subcutaneous Medicine Delivery Devices Market Research Report 2022

Table of Contents
1 Subcutaneous Medicine Delivery Devices Market Overview
1.1 Product Overview and Scope of Subcutaneous Medicine Delivery Devices
1.2 Subcutaneous Medicine Delivery Devices Segment by Type
1.2.1 Global Subcutaneous Medicine Delivery Devices Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Implantable Subcutaneous Medicine Delivery Device
1.2.3 Injection Type Subcutaneous Medicine Delivery Device
1.3 Subcutaneous Medicine Delivery Devices Segment by Application
1.3.1 Global Subcutaneous Medicine Delivery Devices Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Subcutaneous Medicine Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Medicine Delivery Devices Revenue 2017-2028
1.4.2 Global Subcutaneous Medicine Delivery Devices Sales 2017-2028
1.4.3 Subcutaneous Medicine Delivery Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Subcutaneous Medicine Delivery Devices Market Competition by Manufacturers
2.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Manufacturers (2017-2022)
2.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Subcutaneous Medicine Delivery Devices Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Subcutaneous Medicine Delivery Devices Manufacturing Sites, Area Served, Product Type
2.5 Subcutaneous Medicine Delivery Devices Market Competitive Situation and Trends
2.5.1 Subcutaneous Medicine Delivery Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Subcutaneous Medicine Delivery Devices Players Market Share by Revenue
2.5.3 Global Subcutaneous Medicine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Subcutaneous Medicine Delivery Devices Retrospective Market Scenario by Region
3.1 Global Subcutaneous Medicine Delivery Devices Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Subcutaneous Medicine Delivery Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.3.1 North America Subcutaneous Medicine Delivery Devices Sales by Country
3.3.2 North America Subcutaneous Medicine Delivery Devices Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.4.1 Europe Subcutaneous Medicine Delivery Devices Sales by Country
3.4.2 Europe Subcutaneous Medicine Delivery Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Subcutaneous Medicine Delivery Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Subcutaneous Medicine Delivery Devices Sales by Region
3.5.2 Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.6.1 Latin America Subcutaneous Medicine Delivery Devices Sales by Country
3.6.2 Latin America Subcutaneous Medicine Delivery Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Subcutaneous Medicine Delivery Devices Sales by Country
3.7.2 Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Subcutaneous Medicine Delivery Devices Historic Market Analysis by Type
4.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2017-2022)
4.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2017-2022)
4.3 Global Subcutaneous Medicine Delivery Devices Price by Type (2017-2022)
5 Global Subcutaneous Medicine Delivery Devices Historic Market Analysis by Application
5.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2017-2022)
5.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application (2017-2022)
5.3 Global Subcutaneous Medicine Delivery Devices Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Eli Lily
6.2.1 Eli Lily Corporation Information
6.2.2 Eli Lily Description and Business Overview
6.2.3 Eli Lily Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Eli Lily Subcutaneous Medicine Delivery Devices Product Portfolio
6.2.5 Eli Lily Recent Developments/Updates
6.3 Galaxo
6.3.1 Galaxo Corporation Information
6.3.2 Galaxo Description and Business Overview
6.3.3 Galaxo Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Galaxo Subcutaneous Medicine Delivery Devices Product Portfolio
6.3.5 Galaxo Recent Developments/Updates
6.4 HMD pharmaceuticals
6.4.1 HMD pharmaceuticals Corporation Information
6.4.2 HMD pharmaceuticals Description and Business Overview
6.4.3 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product Portfolio
6.4.5 HMD pharmaceuticals Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Merck Subcutaneous Medicine Delivery Devices Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Novartis Subcutaneous Medicine Delivery Devices Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novo Nordisk Subcutaneous Medicine Delivery Devices Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Pfizer Subcutaneous Medicine Delivery Devices Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Sanofi Subcutaneous Medicine Delivery Devices Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Teva Pharmaceutical
6.10.1 Teva Pharmaceutical Corporation Information
6.10.2 Teva Pharmaceutical Description and Business Overview
6.10.3 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product Portfolio
6.10.5 Teva Pharmaceutical Recent Developments/Updates
6.11 Zogenix
6.11.1 Zogenix Corporation Information
6.11.2 Zogenix Subcutaneous Medicine Delivery Devices Description and Business Overview
6.11.3 Zogenix Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Zogenix Subcutaneous Medicine Delivery Devices Product Portfolio
6.11.5 Zogenix Recent Developments/Updates
6.12 BD
6.12.1 BD Corporation Information
6.12.2 BD Subcutaneous Medicine Delivery Devices Description and Business Overview
6.12.3 BD Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.12.4 BD Subcutaneous Medicine Delivery Devices Product Portfolio
6.12.5 BD Recent Developments/Updates
6.13 Insulet Corporation
6.13.1 Insulet Corporation Corporation Information
6.13.2 Insulet Corporation Subcutaneous Medicine Delivery Devices Description and Business Overview
6.13.3 Insulet Corporation Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Insulet Corporation Subcutaneous Medicine Delivery Devices Product Portfolio
6.13.5 Insulet Corporation Recent Developments/Updates
6.14 Enable Injections
6.14.1 Enable Injections Corporation Information
6.14.2 Enable Injections Subcutaneous Medicine Delivery Devices Description and Business Overview
6.14.3 Enable Injections Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Enable Injections Subcutaneous Medicine Delivery Devices Product Portfolio
6.14.5 Enable Injections Recent Developments/Updates
6.15 West Pharmaceutical Services
6.15.1 West Pharmaceutical Services Corporation Information
6.15.2 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Description and Business Overview
6.15.3 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.15.4 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product Portfolio
6.15.5 West Pharmaceutical Services Recent Developments/Updates
6.16 Ypsomed AG
6.16.1 Ypsomed AG Corporation Information
6.16.2 Ypsomed AG Subcutaneous Medicine Delivery Devices Description and Business Overview
6.16.3 Ypsomed AG Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Ypsomed AG Subcutaneous Medicine Delivery Devices Product Portfolio
6.16.5 Ypsomed AG Recent Developments/Updates
6.17 Elcam Medical
6.17.1 Elcam Medical Corporation Information
6.17.2 Elcam Medical Subcutaneous Medicine Delivery Devices Description and Business Overview
6.17.3 Elcam Medical Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Elcam Medical Subcutaneous Medicine Delivery Devices Product Portfolio
6.17.5 Elcam Medical Recent Developments/Updates
6.18 Amgen
6.18.1 Amgen Corporation Information
6.18.2 Amgen Subcutaneous Medicine Delivery Devices Description and Business Overview
6.18.3 Amgen Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Amgen Subcutaneous Medicine Delivery Devices Product Portfolio
6.18.5 Amgen Recent Developments/Updates
6.19 Wilhelm Haselmeier
6.19.1 Wilhelm Haselmeier Corporation Information
6.19.2 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Description and Business Overview
6.19.3 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product Portfolio
6.19.5 Wilhelm Haselmeier Recent Developments/Updates
7 Subcutaneous Medicine Delivery Devices Manufacturing Cost Analysis
7.1 Subcutaneous Medicine Delivery Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Subcutaneous Medicine Delivery Devices
7.4 Subcutaneous Medicine Delivery Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Subcutaneous Medicine Delivery Devices Distributors List
8.3 Subcutaneous Medicine Delivery Devices Customers
9 Subcutaneous Medicine Delivery Devices Market Dynamics
9.1 Subcutaneous Medicine Delivery Devices Industry Trends
9.2 Subcutaneous Medicine Delivery Devices Market Drivers
9.3 Subcutaneous Medicine Delivery Devices Market Challenges
9.4 Subcutaneous Medicine Delivery Devices Market Restraints
10 Global Market Forecast
10.1 Subcutaneous Medicine Delivery Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Subcutaneous Medicine Delivery Devices by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Subcutaneous Medicine Delivery Devices by Type (2023-2028)
10.2 Subcutaneous Medicine Delivery Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Subcutaneous Medicine Delivery Devices by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Subcutaneous Medicine Delivery Devices by Application (2023-2028)
10.3 Subcutaneous Medicine Delivery Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Subcutaneous Medicine Delivery Devices by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Subcutaneous Medicine Delivery Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Subcutaneous Medicine Delivery Devices Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Subcutaneous Medicine Delivery Devices Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Subcutaneous Medicine Delivery Devices Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Subcutaneous Medicine Delivery Devices Market Competitive Situation by Manufacturers in 2021
Table 5. Global Subcutaneous Medicine Delivery Devices Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Subcutaneous Medicine Delivery Devices Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Subcutaneous Medicine Delivery Devices Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Subcutaneous Medicine Delivery Devices Average Price (K USD/K Units) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Subcutaneous Medicine Delivery Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Subcutaneous Medicine Delivery Devices Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Subcutaneous Medicine Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Medicine Delivery Devices as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Subcutaneous Medicine Delivery Devices Sales by Region (2017-2022) & (K Units)
Table 16. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2017-2022)
Table 17. Global Subcutaneous Medicine Delivery Devices Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2017-2022)
Table 19. North America Subcutaneous Medicine Delivery Devices Sales by Country (2017-2022) & (K Units)
Table 20. North America Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2017-2022)
Table 21. North America Subcutaneous Medicine Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2017-2022)
Table 23. Europe Subcutaneous Medicine Delivery Devices Sales by Country (2017-2022) & (K Units)
Table 24. Europe Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2017-2022)
Table 25. Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Subcutaneous Medicine Delivery Devices Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2017-2022)
Table 31. Latin America Subcutaneous Medicine Delivery Devices Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2017-2022)
Table 33. Latin America Subcutaneous Medicine Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Subcutaneous Medicine Delivery Devices Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2017-2022)
Table 39. Global Subcutaneous Medicine Delivery Devices Sales by Type (2017-2022) & (K Units)
Table 40. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2017-2022)
Table 41. Global Subcutaneous Medicine Delivery Devices Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Subcutaneous Medicine Delivery Devices Revenue Share by Type (2017-2022)
Table 43. Global Subcutaneous Medicine Delivery Devices Price by Type (2017-2022) & (K USD/K Units)
Table 44. Global Subcutaneous Medicine Delivery Devices Sales (K Units) by Application (2017-2022)
Table 45. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2017-2022)
Table 46. Global Subcutaneous Medicine Delivery Devices Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Subcutaneous Medicine Delivery Devices Revenue Share by Application (2017-2022)
Table 48. Global Subcutaneous Medicine Delivery Devices Price by Application (2017-2022) & (K USD/K Units)
Table 49. Boehringer Ingelheim Corporation Information
Table 50. Boehringer Ingelheim Description and Business Overview
Table 51. Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 52. Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product
Table 53. Boehringer Ingelheim Recent Developments/Updates
Table 54. Eli Lily Corporation Information
Table 55. Eli Lily Description and Business Overview
Table 56. Eli Lily Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 57. Eli Lily Subcutaneous Medicine Delivery Devices Product
Table 58. Eli Lily Recent Developments/Updates
Table 59. Galaxo Corporation Information
Table 60. Galaxo Description and Business Overview
Table 61. Galaxo Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 62. Galaxo Subcutaneous Medicine Delivery Devices Product
Table 63. Galaxo Recent Developments/Updates
Table 64. HMD pharmaceuticals Corporation Information
Table 65. HMD pharmaceuticals Description and Business Overview
Table 66. HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 67. HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product
Table 68. HMD pharmaceuticals Recent Developments/Updates
Table 69. Merck Corporation Information
Table 70. Merck Description and Business Overview
Table 71. Merck Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 72. Merck Subcutaneous Medicine Delivery Devices Product
Table 73. Merck Recent Developments/Updates
Table 74. Novartis Corporation Information
Table 75. Novartis Description and Business Overview
Table 76. Novartis Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 77. Novartis Subcutaneous Medicine Delivery Devices Product
Table 78. Novartis Recent Developments/Updates
Table 79. Novo Nordisk Corporation Information
Table 80. Novo Nordisk Description and Business Overview
Table 81. Novo Nordisk Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 82. Novo Nordisk Subcutaneous Medicine Delivery Devices Product
Table 83. Novo Nordisk Recent Developments/Updates
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Business Overview
Table 86. Pfizer Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 87. Pfizer Subcutaneous Medicine Delivery Devices Product
Table 88. Pfizer Recent Developments/Updates
Table 89. Sanofi Corporation Information
Table 90. Sanofi Description and Business Overview
Table 91. Sanofi Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 92. Sanofi Subcutaneous Medicine Delivery Devices Product
Table 93. Sanofi Recent Developments/Updates
Table 94. Teva Pharmaceutical Corporation Information
Table 95. Teva Pharmaceutical Description and Business Overview
Table 96. Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 97. Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product
Table 98. Teva Pharmaceutical Recent Developments/Updates
Table 99. Zogenix Corporation Information
Table 100. Zogenix Description and Business Overview
Table 101. Zogenix Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 102. Zogenix Subcutaneous Medicine Delivery Devices Product
Table 103. Zogenix Recent Developments/Updates
Table 104. BD Corporation Information
Table 105. BD Description and Business Overview
Table 106. BD Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 107. BD Subcutaneous Medicine Delivery Devices Product
Table 108. BD Recent Developments/Updates
Table 109. Insulet Corporation Corporation Information
Table 110. Insulet Corporation Description and Business Overview
Table 111. Insulet Corporation Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 112. Insulet Corporation Subcutaneous Medicine Delivery Devices Product
Table 113. Insulet Corporation Recent Developments/Updates
Table 114. Enable Injections Corporation Information
Table 115. Enable Injections Description and Business Overview
Table 116. Enable Injections Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 117. Enable Injections Subcutaneous Medicine Delivery Devices Product
Table 118. Enable Injections Recent Developments/Updates
Table 119. West Pharmaceutical Services Corporation Information
Table 120. West Pharmaceutical Services Description and Business Overview
Table 121. West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 122. West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product
Table 123. West Pharmaceutical Services Recent Developments/Updates
Table 124. Ypsomed AG Corporation Information
Table 125. Ypsomed AG Description and Business Overview
Table 126. Ypsomed AG Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 127. Ypsomed AG Subcutaneous Medicine Delivery Devices Product
Table 128. Ypsomed AG Recent Developments/Updates
Table 129. Elcam Medical Corporation Information
Table 130. Elcam Medical Description and Business Overview
Table 131. Elcam Medical Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 132. Elcam Medical Subcutaneous Medicine Delivery Devices Product
Table 133. Elcam Medical Recent Developments/Updates
Table 134. Amgen Corporation Information
Table 135. Amgen Description and Business Overview
Table 136. Amgen Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 137. Amgen Subcutaneous Medicine Delivery Devices Product
Table 138. Amgen Recent Developments/Updates
Table 139. Wilhelm Haselmeier Corporation Information
Table 140. Wilhelm Haselmeier Description and Business Overview
Table 141. Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 142. Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product
Table 143. Wilhelm Haselmeier Recent Developments/Updates
Table 144. Production Base and Market Concentration Rate of Raw Material
Table 145. Key Suppliers of Raw Materials
Table 146. Subcutaneous Medicine Delivery Devices Distributors List
Table 147. Subcutaneous Medicine Delivery Devices Customers List
Table 148. Subcutaneous Medicine Delivery Devices Market Trends
Table 149. Subcutaneous Medicine Delivery Devices Market Drivers
Table 150. Subcutaneous Medicine Delivery Devices Market Challenges
Table 151. Subcutaneous Medicine Delivery Devices Market Restraints
Table 152. Global Subcutaneous Medicine Delivery Devices Sales Forecast by Type (2023-2028) & (K Units)
Table 153. Global Subcutaneous Medicine Delivery Devices Sales Market Share Forecast by Type (2023-2028)
Table 154. Global Subcutaneous Medicine Delivery Devices Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 155. Global Subcutaneous Medicine Delivery Devices Revenue Market Share Forecast by Type (2023-2028)
Table 156. Global Subcutaneous Medicine Delivery Devices Sales Forecast by Application (2023-2028) & (K Units)
Table 157. Global Subcutaneous Medicine Delivery Devices Sales Market Share Forecast by Application (2023-2028)
Table 158. Global Subcutaneous Medicine Delivery Devices Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 159. Global Subcutaneous Medicine Delivery Devices Revenue Market Share Forecast by Application (2023-2028)
Table 160. Global Subcutaneous Medicine Delivery Devices Sales Forecast by Region (2023-2028) & (K Units)
Table 161. Global Subcutaneous Medicine Delivery Devices Sales Market Share Forecast by Region (2023-2028)
Table 162. Global Subcutaneous Medicine Delivery Devices Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 163. Global Subcutaneous Medicine Delivery Devices Revenue Market Share Forecast by Region (2023-2028)
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Subcutaneous Medicine Delivery Devices
Figure 2. Global Subcutaneous Medicine Delivery Devices Market Share by Type in 2021 & 2028
Figure 3. Implantable Subcutaneous Medicine Delivery Device Product Picture
Figure 4. Injection Type Subcutaneous Medicine Delivery Device Product Picture
Figure 5. Global Subcutaneous Medicine Delivery Devices Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Subcutaneous Medicine Delivery Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Subcutaneous Medicine Delivery Devices Market Size (2017-2028) & (US$ Million)
Figure 11. Global Subcutaneous Medicine Delivery Devices Sales (2017-2028) & (K Units)
Figure 12. Subcutaneous Medicine Delivery Devices Sales Share by Manufacturers in 2021
Figure 13. Global Subcutaneous Medicine Delivery Devices Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Subcutaneous Medicine Delivery Devices Players: Market Share by Revenue in 2021
Figure 15. Subcutaneous Medicine Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2017-2022)
Figure 17. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Region in 2021
Figure 18. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2017-2022)
Figure 19. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Region in 2021
Figure 20. United States Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2017-2022) &
  • Global Autotransfusion Devices Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 88
    Autotransfusion Devices market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Autotransfusion Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - On Pump Transfusion Devices - Off Pump Transfusion Devices Segment by Applica......
  • Global Automated Sample Storage Systems Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 109
    Automated Sample Storage Systems market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Automated Sample Storage Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - System Units - Reagents - Consumables Segment by App......
  • Global Automated Immunoassay Analyzers Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 113
    Automated Immunoassay Analyzers market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Automated Immunoassay Analyzers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Enhanced Chemiluminescence - Chemiluminescenceies Segment by ......
  • Global Artificial Limbs Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 94
    Artificial Limbs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Artificial Limbs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Lower Body Prosthetic - Upper Body Prosthetic Segment by Application - Vascular Dise......
  • Global Arterial Stents Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 105
    Arterial Stents market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Arterial Stents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Coronary Stents - Peripheral Stents Segment by Application - Coronary Artery - ......
  • Global Antimicrobial Susceptibility Test Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 114
    Antimicrobial Susceptibility Test market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Antimicrobial Susceptibility Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Tests and Kits - Culture Media - Automated......
  • Global Aesthetic Services Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 114
    Aesthetic Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Aesthetic Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Surgical - Non-surgical - Reconstructive Procedures Segme......
  • Global Atelo-Gelatin Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 111
    Atelo-Gelatin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Atelo-Gelatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Bovine Gelatin - Porcine Gelatin - Other Segment by Application - Cosmetics ......
  • Global Poliglecaprone Suture Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 113
    Poliglecaprone Suture market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Poliglecaprone Suture market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Dyed - Undyed Segment by Application - Skin Closure - General Soft ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs